RAINBOW Rainbow Childrens Medicare Q4 FY26 results (Jan–Mar 2026) and concall
Rainbow Children's Medicare Limited delivered strong Q4 FY26 results with significant revenue and profit growth, driven by record bed additions and successful integration of new facilities. The company is focused on enhancing operational efficiency, expanding specialty services, and leveraging technology for future growth, while addressing challenges from geopolitical impacts on international business and past seasonal demand fluctuations.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
Q4 FY26: revenue up 24.3%, net profit up 36.8% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|
| Revenue | 417 | 398 | 370 | 353 | 445 +7% | 445 +12% | 460 +24% |
| EBITDA | 147 | 134 | 115 | 104 | 149 +1% | 147 +10% | 145 +26% |
| Net profit | 79 | 69 | 57 | 54 | 76 −4% | 74 +7% | 78 +37% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.





